{"disease":{"id":"evaluate-the-safety-and-tolerability","name":"evaluate the safety and tolerability"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07518589","title":"Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Shenzhen Kangzhe Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07300202","title":"CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Oriplantee Company Limited","has_results":false},{"nct_id":"NCT06022744","title":"An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}